Buy, Sell, Hold: 4 stocks and 1 event are on analysts’ radar today

Marico, NTPC, and Sun Pharma, among others, are being tracked by investors on Thursday.

Addl Borrowing

Brokerage: IDFC

The broking firm said that fears of bond traders come true as government announces additional borrowing. Further, the government could head towards a fisc gap of additional 0.4% of GDP in FY18. Even as the market was factoring in some slippage in FY, gap appears to be large.

Brokerage: Citi

Addl Borrowing

Brokerage: IDFC

The broking firm said that fears of bond traders come true as government announces additional borrowing. Further, the government could head towards a fisc gap of additional 0.4% of GDP in FY18. Even as the market was factoring in some slippage in FY, gap appears to be large.

Brokerage: Citi

Marico

Brokerage: Antique | Rating: Buy | Target: Rs 363

Antique expects the firm to post 8% like-to-like growth in Q3 cons revenue. It estimate profit at rs 210 crore (10% yoy growth) in Q3. Parachute oil & value added hair oils continued to post double digit volume growth. It expects Bangladesh to record double digit constant currency growth.

Mahindra CIE

Brokerage: Motilal | Rating: Initiate coverage with a buy | Target: Rs 297

The brokerage expects consolidation & operating leverage to drive 29% EPS CAGR. Further, the firm is primed for a growth phase, after three years of consolidation. All ingredients are in place for sustained growth.

Sun Pharma

Brokerage: Goldman Sachs | Rating: Buy | Target: Rs 600

The global investment bank said that delayed Halol resolution & US price erosion intensity key risks. Further, the US FDA accepting NDA filing of OTX-101, is in-line with expectations.

NTPC

Brokerage: Motilal | Rating: Buy | Target: Rs 211

The brokerage said that declining PLF is impacting operating efficiencies of plants. Lower coal cost & relaxed regulatory norms provide some relief and revised regulatory norms can compensate earnings by 2 percent. As capitalisation outpaces capex, RoE will get a boost.

Capital Ways Investment Adviser
605, Industry House , AB road Indore (MP) 452001
7771800797, 8517810864

https://www.capitalways.com/

 Free Trial

0 comments:

Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma with a stop loss of Rs 731 for target of Rs 696 and Bank of Baroda...